BFA
PBYI icon

BlackRock Fund Advisors’s Puma Biotechnology PBYI Stock Holding History

BlackRock Fund Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$25.9M Buy
842,478
+216,454
+35% +$9.36M ﹤0.01% 2038
2016
Q3 		$42M Buy
626,024
+23,953
+4% +$1.21M 0.01% 1694
2016
Q2 		$17.9M Buy
602,071
+371,151
+161% +$11.6M ﹤0.01% 2087
2016
Q1 		$6.78M Sell
230,920
-11,504
-5% -$520K ﹤0.01% 2579
2015
Q4 		$19M Buy
242,424
+15,071
+7% +$1.18M ﹤0.01% 2078
2015
Q3 		$17.1M Sell
227,353
-1,689
-0.7% -$160K ﹤0.01% 2092
2015
Q2 		$26.7M Sell
229,042
-420,898
-65% -$76.2M 0.01% 1933
2015
Q1 		$153M Buy
649,940
+46,858
+8% +$10M 0.04% 659
2014
Q4 		$114M Buy
603,082
+66,576
+12% +$14.8M 0.03% 830
2014
Q3 		$128M Buy
536,506
+7,195
+1% +$1.48M 0.04% 660
2014
Q2 		$34.9M Sell
529,311
-52,428
-9% -$3.73M 0.01% 1649
2014
Q1 		$60.6M Buy
581,739
+38,146
+7% +$4.48M 0.02% 1268
2013
Q4 		$56.3M Sell
543,593
-26,542
-5% -$1.56M 0.02% 1312
2013
Q3 		$30.6M Buy
570,135
+66,037
+13% +$3.56M 0.01% 1683
2013
Q2 		$22.4M Buy
+504,098
New +$17.8M 0.01% 1780

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BlackRock Fund Advisors's PBYI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Puma Biotechnology (PBYI) stake by 35% in Q4 2016, buying an estimated $9.36M and bringing the position to 842,478 shares worth $25.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2038.

BlackRock Fund Advisors first reported a position in PBYI in Q2 2013 and has held it in 15 quarters since. The position peaked at $153M in Q1 2015. 128 funds tracked by Wall St. Rank hold PBYI as of Q4 2016.

  • BlackRock Fund Advisors held 842,478 shares of Puma Biotechnology worth $25.9M as of Q4 2016.
  • BlackRock Fund Advisors bought 216,454 Puma Biotechnology shares in Q4 2016, an estimated $9.36M.
  • Puma Biotechnology made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2038 holding.
  • BlackRock Fund Advisors first reported a position in Puma Biotechnology in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Puma Biotechnology position peaked at $153M in Q1 2015.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.